ADIAL PHARMACEUTICALS INC's ticker is ADILW and the CUSIP is 00688A114. A total of 3 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39 | – | 6,534 | +326600.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 2 | -100.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 4,961 | +33.4% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 3,719 | -0.6% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 3,743 | -57.1% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 8,716 | -3.9% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 9,074 | -4.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 9,502 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 9,502 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 9,502 | +43.6% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 6,617 | +62.1% | 0.00% | – |
| Q4 2018 | $2,000 | – | 4,081 | +408000.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 9,502 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |